retatrutide study sign up obesity trial results in 28 percent average weight loss Phase III retatrutide demonstrates – How To Get Retatrutide with

Look ARG, Gregg EW, Jakicic JM et al (2016) Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial

Research suggests that between 10% and 30% of patients fit into this group

About 25% of coverage questions get answered incorrectly on the first call according to a 2024 KFF analysis, so dont take the first answer as final

Reference: Loguercio, C., Taranto, D., Beneduce, F., del Vecchio Blanco, C., de Vincentiis, A., Nardi, G., & Romano, M

Jastreboff AM, Aronne LJ, Ahmad N et al (2022) Tirzepatide once weekly for the treatment of obesity